In vivo studies further demonstrate that SPRC mitigates inflammatory responses by modulating the Nrf2-ARE signaling pathway, alleviating adjuvant-induced arthritis in rats (Wu et al. 2016; Wang et al. 2021a, b). The gene discussed is SPRR3; the disease is arthritic joint disease.